Related Experiment Video
Updated: Jan 15, 2026

Training Persons with Spinal Cord Injury to Ambulate Using a Powered Exoskeleton
Published on: June 16, 2016
The Development of Can Walk Can Run: A Walking and Running Program for People Living With and Beyond Cancer
Christopher T V Swain1,2, Rebecca J Bergin2,3,4, Melissa Moore5,6
1Department of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Background:
Finding new ways to support physical activity participation after cancer is an important challenge. This research aimed to develop a walking and running program that could support people living with and beyond cancer to participate in fun run-style events.
Methods:
Mixed methods research that followed guidance for developing complex interventions was conducted in 2 phases. Phase 1 included a review of published evidence, stakeholder consultation, and co-design workshops, which were used to develop an initial program protocol. Phase 2 included iterative piloting of the program, via delivery of it prior to 3 separately sponsored fun runs, to test and refine the protocol.
Results:
In Phase 1, 38 reviews, identified via systematic search, 15 stakeholders, including potential program referrers, managers or sponsors, and 8 co-design participants, including people with lived experience of cancer, and program delivery staff contributed to the initial protocol development. Protocol elements generated, included selection of location and delivery staff, tailoring of physical activity content, use of inclusive language, and strategies to support social connection. In Phase 2, 17 participants with lived experience of cancer participated in the program during iterative piloting. Protocol modifications, included expansion of the program goals beyond fun run participation, as well as the development of remote support strategies to facilitate continued engagement and further opportunities for physical activity prescription.
Conclusions:
Utilizing an iterative methodological approach and being open to protocol change allowed us to address the preferences of diverse stakeholders and to optimize the practical program aspects prior to larger scale trials.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Prevention
Some...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...

